Abstract
The Alzheimer's disease beta-amyloid peptide (Abeta) is produced by excision from the type 1 integral membrane glycoprotein amyloid precursor protein (APP) by the sequential actions of beta- and then gamma-secretases. Here we report that Asp 2, a novel transmembrane aspartic protease, has the key activities expected of beta-secretase. Transient expression of Asp 2 in cells expressing APP causes an increase in the secretion of the N-terminal fragment of APP and an increase in the cell-associated C-terminal beta-secretase APP fragment. Mutation of either of the putative catalytic aspartyl residues in Asp 2 abrogates the production of the fragments characteristic of cleavage at the beta-secretase site. The enzyme is present in normal and Alzheimer's disease (AD) brain and is also found in cell lines known to produce Abeta. Asp 2 localizes to the Golgi/endoplasmic reticulum in transfected cells and shows clear colocalization with APP in cells stably expressing the 751-amino-acid isoform of APP.
Original language | English |
---|---|
Pages (from-to) | 419-27 |
Number of pages | 9 |
Journal | Molecular and Cellular Neuroscience |
Volume | 14 |
Issue number | 6 |
DOIs | |
Publication status | Published - Dec 1999 |
Keywords / Materials (for Non-textual outputs)
- Alzheimer Disease
- Amino Acid Sequence
- Amino Acid Substitution
- Amyloid Precursor Protein Secretases
- Amyloid beta-Protein Precursor
- Animals
- Aspartic Acid Endopeptidases
- COS Cells
- Cathepsin D
- Cell Line
- Cell Membrane
- Endopeptidases
- Female
- Hippocampus
- Humans
- Middle Aged
- Molecular Sequence Data
- Mutagenesis, Site-Directed
- Papain
- Recombinant Proteins
- Sequence Alignment
- Sequence Homology, Amino Acid
- Transfection